Form 4: Eli Lilly Executive Edgardo Hernandez Reports Stock Transactions
SEC Form 4 Filing
EVP Edgardo Hernandez reports the acquisition and disposal of Eli Lilly common stock and restricted stock units on February 1, 2025.
Summary
- On February 1, 2025, Edgardo Hernandez, an EVP at Eli Lilly & Co, reported transactions involving the company's stock.
- Hernandez acquired 2,861 shares of common stock through the vesting of restricted stock units.
- Simultaneously, 1,281.582 shares were disposed of to cover tax obligations at a price of $811.08.
- Following these transactions, Hernandez directly owns 32,197.619 shares of common stock and indirectly owns 866.62 shares through a 401(k) plan.
- He also disposed of 2,861 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is standard practice for publicly traded companies.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent routine executive compensation activities.
Key Dates
| Date | Description |
|---|---|
| 02/01/2025 | Date of earliest transaction: acquisition of common stock and disposal of shares for tax obligations. |
| 02/01/2025 | Restricted Stock Unit exercisable and expiration date. |
| 02/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.